dlx5 has 28 expression phenotype(s)
Page: 1 2 3 ???pagination.result.next???
Images Sources Experiment + Assay Phenotypes Human Diseases
Fig. 7 C r1c2, r2c2; D E

Baxi AB et al. (2023)
Xla Wt + tgfbi MO

NF32 (in situ hybridization)
Anatomical Phenotype
decreased size of the otic vesicle
Expression Phenotype
decreased amount dlx5.L expression in otic vesicle
decreased amount dlx5.L expression in pharyngeal arch
decreased amount pax2.L expression in otic vesicle
Fig.5.B,E,H,K

Tavares ALP et al. (2021)
Xla Wt + sobp

NF28-33/34 (in situ hybridization)
Anatomical Phenotype
decreased size of the otic vesicle
Expression Phenotype
decreased amount dlx5.L expression in otic vesicle
increased amount dlx5.L expression in otic vesicle
decreased amount six1.L expression in otic vesicle
increased amount pax2.L expression in otic vesicle
mislocalised pax2.L expression in otic vesicle
Fig.5.D,G,J

Tavares ALP et al. (2021)
Xla Wt + sobp CRISPR

NF28-33/34 (in situ hybridization)
Anatomical Phenotype
decreased size of the otic vesicle
Expression Phenotype
decreased amount dlx5.L expression in otic vesicle
decreased amount pax2.L expression in otic vesicle
decreased amount six1.L expression in otic vesicle
Fig.5.M

Tavares ALP et al. (2021)
Xla Wt + sobp CRISPR

NF28-33/34 (RT-PCR)
Expression Phenotype
decreased amount dlx5.L expression in the embryo
decreased amount pax2.L expression in embryo
Fig.5.C,F,I,L

Tavares ALP et al. (2021)
Xla Wt + sobpR651X

NF28-33/34 (in situ hybridization)
Expression Phenotype
decreased amount dlx5.L expression in otic vesicle
decreased amount six1.L expression in otic vesicle
increased amount pax2.L expression in otic vesicle
Fig. 4 D. Fig. 5 G

Shah AM et al. (2020)
Xla Wt + six1

NF28-32 (in situ hybridization)
Expression Phenotype
decreased amount dlx5.L expression in otic vesicle
branchiootic syndrome
branchiootorenal syndrome
Fig. 4 D

Shah AM et al. (2020)
Xla Wt + six1

NF28-32 (in situ hybridization)
Expression Phenotype
decreased amount dlx5.L expression in otic vesicle
branchiootic syndrome
branchiootorenal syndrome
Fig. 4 D

Shah AM et al. (2020)
Xla Wt + six1-R110W

NF28-32 (in situ hybridization)
Expression Phenotype
increased amount dlx5.L expression in otic vesicle
branchiootic syndrome
branchiootorenal syndrome
Fig. 4 D, Fig. 5 H

Shah AM et al. (2020)
Xla Wt + six1-V17E

NF28-32 (in situ hybridization)
Expression Phenotype
decreased amount dlx5.L expression in otic vesicle
branchiootic syndrome
branchiootorenal syndrome
Fig. 4 D

Shah AM et al. (2020)
Xla Wt + six1-W122R

NF28-32 (in situ hybridization)
Expression Phenotype
decreased amount dlx5.L expression in otic vesicle
branchiootic syndrome
branchiootorenal syndrome